Thermo Fisher's $1.39B Trading Volume Surges 58.74% to 65th Market Rank Amid Divergent Institutional Bets

Thermo Fisher Scientific (TMO) saw a surge in trading activity on Sept. 29, 2025, with $1.39 billion in volume, a 58.74% rise from the previous day, ranking it 65th in market activity. The stock closed down 0.47% amid mixed institutional investor activity.

Invesco LLC reduced its stake in TMO by 8.9% during Q2, holding 10,168 shares valued at $4.12 million. Meanwhile, several firms increased holdings, including Revolve Wealth Partners (4.2% boost) and Intergy Private Wealth (5.8% increase), reflecting divergent institutional sentiment. Insiders also sold shares, with Chief Accounting Officer Joseph Holmes offloading 385 shares in August and EVP Gianluca Pettiti selling 400 shares in July, trimming their holdings by 14.24% and 1.76%, respectively.

The company reported Q2 earnings of $5.36 per share, exceeding estimates, and generated $10.86 billion in revenue, a 2.9% year-over-year increase. Thermo Fisher also announced a $0.43 quarterly dividend, yielding 0.4% annually, with a payout ratio of 9.95%. Analysts have set a range of $22.22–$22.84 EPS for FY 2025, though recent ratings include "outperform" from William Blair and Raymond James and a "hold" from Hsbc Global.

To run this back-test rigorously, the strategy assumes a universe of all primary-listed U.S. common stocks with valid prior-day price/volume data, ranks by dollar trading volume, and executes trades at the next-day open/close. The portfolio is equal-weighted and re-balanced daily, with no explicit costs. Performance metrics include returns, volatility, Sharpe ratio, max drawdown, and turnover. The full tear-sheet will cover daily portfolio returns from Jan. 3, 2022, to the latest available date.